Journal of Gastroenterology
Springer Science+Business Media · JP · ISSN 09441174
动向摘要
More papers are appearing but each one is getting fewer citations on average.
Field-weighted citation impact moved from 3.57 to 2.56. If you rely on high citedness per paper, look elsewhere. Output grew sharply while citation impact fell. Expect a busier publication roster that may dilute average attention per article. Inflammatory Bowel Disease rose from 10.5% to 18.4% of what the journal runs. Consider submitting if your work is on inflammatory bowel disease. The University of Tokyo leads all institutions with 93 papers. Readers should note a strong institutional concentration among contributors.
引用指标
基于 Scopus 与 OpenAlex 引用图谱。本站不提供 Clarivate 的 JCR 影响因子。
发文量与被引表现
发文量增长时被引表现是否同步。
主题变化
对比近 24 个月(2024-09 – 2026-08)与此前 24 个月(2022-09 – 2024-08)的占比。
- Inflammatory Bowel Disease10.5%→18.4%+7.9%p此前近期
- Hepatocellular Carcinoma Treatment and Prognosis2.5%→7.2%+4.8%p此前近期
- Gallbladder and Bile Duct Disorders0.0%→2.4%+2.4%p此前近期
- Gut microbiota and health0.0%→2.4%+2.4%p此前近期
- Extracellular vesicles in disease0.0%→2.4%+2.4%p此前近期
- Colorectal Cancer Screening and Detection4.3%→0.0%−4.3%p此前近期
- Liver Disease and Transplantation9.9%→5.8%−4.1%p此前近期
- Genetic factors in colorectal cancer3.7%→0.0%−3.7%p此前近期
- Pancreatitis Pathology and Treatment3.1%→0.0%−3.1%p此前近期
- Gastric Cancer Management and Outcomes8.0%→5.3%−2.7%p此前近期
近期高频术语
近期论文标题中相较以往显著增加的表述。
作者国家构成
将近 24 个月(2024-09 – 2026-08)与此前 24 个月(2022-09 – 2024-08)并列显示。
- JP64.0%→58.9%−5.1%p此前近期
- CN16.4%→21.8%+5.4%p此前近期
- US9.2%→9.8%+0.6%p此前近期
- DE0.0%→2.2%+2.2%p此前近期
- KR2.0%→2.2%+0.2%p此前近期
- TW0.0%→2.0%+2.0%p此前近期
机构发文 Top 5
2018 – 2026 期间在该期刊发表论文的前 5 家机构。
近期发表论文
20按发表日期最新的 20 篇,并非全部。
高被引论文
202018 – 2026 期间被引最高的 20 篇。
相似期刊
数据截至 2026-09-05